{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:02:40Z","timestamp":1793016160469,"version":"4.5.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Chen Xiao-Ping Foundation for The Development of Science and Technology of Hubei Province","award":["CXPJJH12000005-07-37"],"award-info":[{"award-number":["CXPJJH12000005-07-37"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-025-11357-7","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:46:43Z","timestamp":1765370803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ketamine enantiomers and the gut microbiota: mechanisms, clinical implications, and future directions"],"prefix":"10.1007","volume":"53","author":[{"given":"Jin-Xi","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Wen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"issue":"12","key":"11357_CR1","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1038\/s41380-023-02139-3","volume":"28","author":"L Musazzi","year":"2023","unstructured":"Musazzi L, Mingardi J, Ieraci A et al (2023) Stress, microRNAs, and stress-related psychiatric disorders: an overview. Mol Psychiatry 28(12):4977\u20134994","journal-title":"Mol Psychiatry"},{"key":"11357_CR2","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291725000649","volume":"55","author":"Y Liu","year":"2025","unstructured":"Liu Y, Ren Y, Liu C et al (2025) Global burden of mental disorders in children and adolescents before and during the COVID-19 pandemic: evidence from the Global Burden of Disease Study 2021. Psychol Med 55:e90","journal-title":"Psychol Med"},{"issue":"1","key":"11357_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-93923-4","volume":"15","author":"J Zhou","year":"2025","unstructured":"Zhou J, Zhang Y, He S et al (2025) Accelerated global burden of depressive disorders during the COVID-19 pandemic from 2019 to 2021. Sci Rep 15(1):9529","journal-title":"Sci Rep"},{"issue":"10","key":"11357_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/pcn.12902","volume":"73","author":"K Hashimoto","year":"2019","unstructured":"Hashimoto K (2019) Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective. Psychiatry Clin Neurosci 73(10):613\u2013627","journal-title":"Psychiatry Clin Neurosci"},{"issue":"1","key":"11357_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1192\/bjp.bp.110.086983","volume":"200","author":"CT Li","year":"2012","unstructured":"Li CT, Bai YM, Huang YL et al (2012) Association between antidepressant resistance in unipolar depression and subsequent bipolar disorder: cohort study. Br J Psychiatry 200(1):45\u201351","journal-title":"Br J Psychiatry"},{"key":"11357_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/7854_2023_452","volume":"66","author":"T Sharp","year":"2024","unstructured":"Sharp T, Collins H (2024) Mechanisms of SSRI therapy and discontinuation[J]. Curr Top Behav Neurosci 66:21\u201347","journal-title":"Curr Top Behav Neurosci"},{"issue":"5","key":"11357_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","volume":"178","author":"RS McIntyre","year":"2021","unstructured":"McIntyre RS, Rosenblat JD, Nemeroff CB et al (2021) Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation. Am J Psychiatry 178(5):383\u2013399","journal-title":"Am J Psychiatry"},{"key":"11357_CR8","doi-asserted-by":"crossref","unstructured":"Wang J, Huang J, Yang S et al (2019) Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study[J]. Drug Design, Development and Therapy, 13: 4135\u20134144","DOI":"10.2147\/DDDT.S224553"},{"issue":"9","key":"11357_CR9","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s40262-016-0383-6","volume":"55","author":"MA Peltoniemi","year":"2016","unstructured":"Peltoniemi MA, Hagelberg NM, Olkkola KT et al (2016) Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet 55(9):1059\u20131077","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"11357_CR10","doi-asserted-by":"publisher","first-page":"e2244514","DOI":"10.1001\/jamanetworkopen.2022.44514","volume":"5","author":"D Qiu","year":"2022","unstructured":"Qiu D, Wang XM, Yang JJ et al (2022) Effect of intraoperative Esketamine infusion on postoperative sleep disturbance after gynecological laparoscopy: A randomized clinical Trial[J]. JAMA Netw Open 5(12):e2244514","journal-title":"JAMA Netw Open"},{"issue":"2","key":"11357_CR11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1213\/ANE.0000000000004194","volume":"129","author":"CL Wu","year":"2019","unstructured":"Wu CL, King AB, Geiger TM et al (2019) American society for enhanced recovery and perioperative quality initiative joint consensus statement on perioperative opioid minimization in opioid-Na\u00efve Patients[J]. Anesth Analg 129(2):567\u2013577","journal-title":"Anesth Analg"},{"issue":"5","key":"11357_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/EJA.0000000000001134","volume":"37","author":"S Eberl","year":"2020","unstructured":"Eberl S, Koers L, van Hooft J et al (2020) The effectiveness of a low-dose Esketamine versus an alfentanil adjunct to Propofol sedation during endoscopic retrograde cholangiopancreatography: A randomised controlled multicentre trial[J]. Eur J Anaesthesiol 37(5):394\u2013401","journal-title":"Eur J Anaesthesiol"},{"issue":"9","key":"11357_CR13","first-page":"936","volume":"38","author":"H Li","year":"2022","unstructured":"Li H, Zhang ZL, Duan CX et al (2022) Effects of low-dose Esketamine combined with sufentanil postoperative analgesia on early cognitive function in elderly patients after hip arthroplasty [J]. J Clin Anesthesiology 38(9):936\u2013939","journal-title":"J Clin Anesthesiology"},{"issue":"2","key":"11357_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0304-3959(94)00170-J","volume":"61","author":"LC Mathisen","year":"1995","unstructured":"Mathisen LC, Skjelbred P, Skoglund LA et al (1995) Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain[J]. Pain 61(2):215\u2013220","journal-title":"Pain"},{"issue":"5","key":"11357_CR15","first-page":"431","volume":"70","author":"H Ihmsen","year":"2001","unstructured":"Ihmsen H, Geisslinger G, Sch\u00fcttler J (2001) Stereoselective pharmacokinetics of ketamine: R(-)-ketamine inhibits the elimination of S(+)-ketamine[J]. Clin Pharmacol Ther 70(5):431\u2013438","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"11357_CR16","doi-asserted-by":"publisher","first-page":"e061535","DOI":"10.1136\/bmjopen-2022-061535","volume":"12","author":"W Wei","year":"2022","unstructured":"Wei W, Zhang A, Liu L et al (2022) Effects of subanaesthetic S-ketamine on postoperative delirium and cognitive function in elderly patients undergoing non-cardiac thoracic surgery: a protocol for a randomised, double-blinded, placebo-controlled and positive-controlled, non-inferiority trial (SKED trial)[J]. BMJ Open 12(8):e061535","journal-title":"BMJ Open"},{"issue":"5","key":"11357_CR17","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/s41380-024-02419-6","volume":"29","author":"R Yokoyama","year":"2024","unstructured":"Yokoyama R, Ago Y, Igarashi H et al (2024) (R)-ketamine restores anterior insular cortex activity and cognitive deficits in social isolation-reared mice[J]. Mol Psychiatry 29(5):1406\u20131416","journal-title":"Mol Psychiatry"},{"issue":"3","key":"11357_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2023.101241","volume":"6","author":"S Ma","year":"2024","unstructured":"Ma S, Dou Y, Wang W et al (2024) Association between esketamine interventions and postpartum depression and analgesia following cesarean delivery: a systematic review and meta-analysis. American journal of obstetrics & gynecology MFM 6(3):101241","journal-title":"American journal of obstetrics & gynecology MFM"},{"issue":"8","key":"11357_CR19","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate CA, Singh JB, Carlson PJ et al (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63(8):856\u2013864","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"11357_CR20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.0953","volume":"7","author":"Y Chen","year":"2024","unstructured":"Chen Y, Guo Y, Wu H et al (2024) Perioperative adjunctive Esketamine for postpartum depression among women undergoing elective cesarean delivery: a randomized clinical trial. JAMA Netw Open 7(3):e240953","journal-title":"JAMA Netw Open"},{"issue":"10","key":"11357_CR21","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1080\/14737175.2019.1640604","volume":"19","author":"J Swainson","year":"2019","unstructured":"Swainson J, Thomas RK, Archer S et al (2019) Esketamine for treatment resistant depression. Expert Rev Neurother 19(10):899\u2013911","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"11357_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0014-2999(97)01116-3","volume":"333","author":"B Ebert","year":"1997","unstructured":"Ebert B, Mikkelsen S, Thorkildsen C et al (1997) Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord. Eur J Pharmacol 333(1):99\u2013104","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"11357_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/00000542-198003000-00008","volume":"52","author":"PF White","year":"1980","unstructured":"White PF, Ham J, Way WL et al (1980) Pharmacology of ketamine isomers in surgical patients. Anesthesiology 52(3):231\u2013239","journal-title":"Anesthesiology"},{"issue":"6","key":"11357_CR24","first-page":"2554","volume":"13","author":"L Sun","year":"2023","unstructured":"Sun L, Zhao Y, Li Y et al (2023) Effect of continuous subanesthetic Esketamine infusion on postoperative fatigue in patients undergoing laparoscopic radical resection for colorectal cancer: a randomized controlled study[J]. Am J Cancer Res 13(6):2554\u20132563","journal-title":"Am J Cancer Res"},{"key":"11357_CR25","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jad.2020.09.071","volume":"278","author":"A Bahji","year":"2021","unstructured":"Bahji A, Vazquez GH, Zarate CA (2021) Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis. J Affect Disord 278:542\u2013555","journal-title":"J Affect Disord"},{"key":"11357_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pbb.2019.04.008","volume":"181","author":"L Chang","year":"2019","unstructured":"Chang L, Zhang K, Pu Y et al (2019) Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine. Pharmacol Biochem Behav 181:53\u201359","journal-title":"Pharmacol Biochem Behav"},{"key":"11357_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108431","volume":"246","author":"JN Johnston","year":"2023","unstructured":"Johnston JN, Henter ID, Zarate CA (2023) The antidepressant actions of ketamine and its enantiomers. Pharmacol Ther 246:108431","journal-title":"Pharmacol Ther"},{"issue":"9","key":"11357_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.136","volume":"5","author":"C Yang","year":"2015","unstructured":"Yang C, Shirayama Y, Zhang Jc et al (2015) R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects. Transl Psychiatry 5(9):e632","journal-title":"Transl Psychiatry"},{"issue":"1","key":"11357_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0624-1","volume":"9","author":"C Yang","year":"2019","unstructured":"Yang C, Yang J, Luo A et al (2019) Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites. Transl Psychiatry 9(1):280","journal-title":"Transl Psychiatry"},{"issue":"9","key":"11357_CR30","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s40263-021-00846-5","volume":"35","author":"F Ceban","year":"2021","unstructured":"Ceban F, Rosenblat JD, Kratiuk K et al (2021) Prevention and management of common adverse effects of ketamine and esketamine in patients with mood disorders. CNS Drugs 35(9):925\u2013934","journal-title":"CNS Drugs"},{"issue":"3","key":"11357_CR31","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.19m12891","volume":"81","author":"E Wajs","year":"2020","unstructured":"Wajs E, Aluisio L, Holder R et al (2020) Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: assessment of long-term safety in a phase 3, open-label study (SUSTAIN-2). J Clin Psychiatry 81(3):19m12891","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"11357_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16060-7","volume":"7","author":"Y Qu","year":"2017","unstructured":"Qu Y, Yang C, Ren Q et al (2017) Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model. Sci Rep 7(1):15725","journal-title":"Sci Rep"},{"issue":"12","key":"11357_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-017-0031-4","volume":"7","author":"C Yang","year":"2017","unstructured":"Yang C, Qu Y, Fujita Y et al (2017) Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model. Transl Psychiatry 7(12):1294","journal-title":"Transl Psychiatry"},{"key":"11357_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109250","volume":"219","author":"L Ma","year":"2022","unstructured":"Ma L, Wang L, Chang L et al (2022) A role of microRNA-149 in the prefrontal cortex for prophylactic actions of (R)-ketamine in inflammation model. Neuropharmacology 219:109250","journal-title":"Neuropharmacology"},{"key":"11357_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.pbb.2018.12.001","volume":"176","author":"N Huang","year":"2019","unstructured":"Huang N, Hua D, Zhan G et al (2019) Role of Actinobacteria and Coriobacteriia in the antidepressant effects of ketamine in an inflammation model of depression. Pharmacol Biochem Behav 176:93\u2013100","journal-title":"Pharmacol Biochem Behav"},{"key":"11357_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2021.173226","volume":"207","author":"Y Wang","year":"2021","unstructured":"Wang Y, Jiang R, Wu Z et al (2021) Gut microbiota is involved in the antidepressant-like effect of (S)-norketamine in an inflammation model of depression. Pharmacol Biochem Behav 207:173226","journal-title":"Pharmacol Biochem Behav"},{"key":"11357_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.109272","volume":"220","author":"H Hua","year":"2022","unstructured":"Hua H, Huang C, Liu H et al (2022) Depression and antidepressant effects of ketamine and its metabolites: the pivotal role of gut microbiota. Neuropharmacology 220:109272","journal-title":"Neuropharmacology"},{"issue":"3","key":"11357_CR38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1590\/s0004-2803.201700000-31","volume":"54","author":"MdoCF Passos","year":"2017","unstructured":"Passos MdoCF, Moraes-Filho JP (2017) INTESTINAL MICROBIOTA IN DIGESTIVE DISEASES. Arq Gastroenterol 54(3):255\u2013262","journal-title":"Arq Gastroenterol"},{"issue":"4","key":"11357_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/nu11040923","volume":"11","author":"S Mills","year":"2019","unstructured":"Mills S, Stanton C, Lane JA et al (2019) Precision nutrition and the microbiome, part I: current state of the science. Nutrients 11(4):923","journal-title":"Nutrients"},{"issue":"7","key":"11357_CR40","first-page":"3225","volume":"95","author":"NC Wiley","year":"2017","unstructured":"Wiley NC, Dinan TG, Ross RP et al (2017) The microbiota-gut-brain axis as a key regulator of neural function and the stress response: implications for human and animal health[J]. J Anim Sci 95(7):3225\u20133246","journal-title":"J Anim Sci"},{"issue":"2","key":"11357_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau8317","volume":"5","author":"P Zheng","year":"2019","unstructured":"Zheng P, Zeng B, Liu M et al (2019) The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Sci Adv 5(2):eaau8317","journal-title":"Sci Adv"},{"issue":"11","key":"11357_CR42","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1136\/gutjnl-2021-326269","volume":"71","author":"C Chen","year":"2022","unstructured":"Chen C, Liao J, Xia Y et al (2022) Gut microbiota regulate Alzheimer\u2019s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation. Gut 71(11):2233\u20132252","journal-title":"Gut"},{"key":"11357_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105840","volume":"172","author":"K Soca\u0142a","year":"2021","unstructured":"Soca\u0142a K, Doboszewska U, Szopa A et al (2021) The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders. Pharmacol Res 172:105840","journal-title":"Pharmacol Res"},{"issue":"1","key":"11357_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0295-y","volume":"8","author":"MJ Bonder","year":"2016","unstructured":"Bonder MJ, Tigchelaar EF, Cai X et al (2016) The influence of a short-term gluten-free diet on the human gut microbiome. Genome Med 8(1):45","journal-title":"Genome Med"},{"key":"11357_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-016-0708-5","volume":"16","author":"T Odamaki","year":"2016","unstructured":"Odamaki T, Kato K, Sugahara H et al (2016) Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol 16:90","journal-title":"BMC Microbiol"},{"key":"11357_CR46","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.7502","volume":"7","author":"N Hasan","year":"2019","unstructured":"Hasan N, Yang H (2019) Factors affecting the composition of the gut microbiota, and its modulation. PeerJ 7:e7502","journal-title":"PeerJ"},{"issue":"8","key":"11357_CR47","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1136\/gutjnl-2019-320204","volume":"69","author":"RK Weersma","year":"2020","unstructured":"Weersma RK, Zhernakova A, Fu J (2020) Interaction between drugs and the gut microbiome. Gut 69(8):1510\u20131519","journal-title":"Gut"},{"issue":"10","key":"11357_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/nu12103009","volume":"12","author":"KL Tooley","year":"2020","unstructured":"Tooley KL (2020) Effects of the human gut microbiota on cognitive performance, brain structure and function: a narrative review. Nutrients 12(10):3009","journal-title":"Nutrients"},{"issue":"19","key":"11357_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911245","volume":"23","author":"A G\u00f3ralczyk-Bi\u0144kowska","year":"2022","unstructured":"G\u00f3ralczyk-Bi\u0144kowska A, Szmajda-Krygier D, Koz\u0142owska E (2022) The microbiota-gut-brain axis in psychiatric disorders. Int J Mol Sci 23(19):11245","journal-title":"Int J Mol Sci"},{"issue":"6","key":"11357_CR50","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1021\/acschemneuro.2c00580","volume":"14","author":"J Xu","year":"2023","unstructured":"Xu J, Tang M, Wang D et al (2023) Lactocaseibacillus rhamnosus zz-1 supplementation mitigates depression-like symptoms in chronic stress-induced depressed mice via the microbiota-gut-brain axis. ACS Chem Neurosci 14(6):1095\u20131106","journal-title":"ACS Chem Neurosci"},{"issue":"12","key":"11357_CR51","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/abbs\/gmz122","volume":"51","author":"T Jiang","year":"2019","unstructured":"Jiang T, Wang R, Yin W et al (2019) Hypothalamic paraventricular nucleus neurons activated by estrogen GPER1 receptors promote anti-inflammation effects in the early stage of colitis. Acta Biochim Biophys Sin 51(12):1216\u20131222","journal-title":"Acta Biochim Biophys Sin"},{"issue":"5","key":"11357_CR52","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","volume":"36","author":"JA Foster","year":"2013","unstructured":"Foster JA, McVey Neufeld KA (2013) Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 36(5):305\u2013312","journal-title":"Trends Neurosci"},{"key":"11357_CR53","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jpsychires.2016.07.019","volume":"82","author":"JR Kelly","year":"2016","unstructured":"Kelly JR, Borre Y, O\u2019 Brien C et al (2016) Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res 82:109\u2013118","journal-title":"J Psychiatr Res"},{"issue":"4","key":"11357_CR54","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41564-018-0337-x","volume":"4","author":"M Valles-Colomer","year":"2019","unstructured":"Valles-Colomer M, Falony G, Darzi Y et al (2019) The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol 4(4):623\u2013632","journal-title":"Nat Microbiol"},{"key":"11357_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/srep43859","volume":"7","author":"IA Marin","year":"2017","unstructured":"Marin IA, Goertz JE, Ren T et al (2017) Microbiota alteration is associated with the development of stress-induced despair behavior. Sci Rep 7:43859","journal-title":"Sci Rep"},{"issue":"2","key":"11357_CR56","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1089\/omi.2017.0077","volume":"22","author":"S Malan-Muller","year":"2018","unstructured":"Malan-Muller S, Valles-Colomer M, Raes J et al (2018) The Gut Microbiome and Mental Health: implications for Anxiety- and Trauma-Related Disorders. Omics: A Journal of Integrative Biology 22(2):90\u2013107","journal-title":"Omics: A Journal of Integrative Biology"},{"issue":"8","key":"11357_CR57","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/s41593-018-0182-5","volume":"21","author":"E Ja\u0161arevi\u0107","year":"2018","unstructured":"Ja\u0161arevi\u0107 E, Howard CD, Morrison K et al (2018) The maternal vaginal microbiome partially mediates the effects of prenatal stress on offspring gut and hypothalamus. Nat Neurosci 21(8):1061\u20131071","journal-title":"Nat Neurosci"},{"issue":"4","key":"11357_CR58","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.celrep.2015.03.049","volume":"11","author":"I Mart\u00ednez","year":"2015","unstructured":"Mart\u00ednez I, Stegen JC, Maldonado-G\u00f3mez MX et al (2015) The gut microbiota of rural papua new guineans: composition, diversity patterns, and ecological processes. Cell Rep 11(4):527\u2013538","journal-title":"Cell Rep"},{"issue":"4","key":"11357_CR59","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.biopsych.2008.07.024","volume":"65","author":"C Cunningham","year":"2009","unstructured":"Cunningham C, Campion S, Lunnon K et al (2009) Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol Psychiatry 65(4):304\u2013312","journal-title":"Biol Psychiatry"},{"key":"11357_CR60","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.psyneuen.2015.10.001","volume":"63","author":"A Bharwani","year":"2016","unstructured":"Bharwani A, Mian MF, Foster JA et al (2016) Structural & functional consequences of chronic psychosocial stress on the microbiome & host. Psychoneuroendocrinology 63:217\u2013227","journal-title":"Psychoneuroendocrinology"},{"issue":"Pt B","key":"11357_CR61","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.neuropharm.2016.07.002","volume":"112","author":"PJ Kennedy","year":"2017","unstructured":"Kennedy PJ, Cryan JF, Dinan TG et al (2017) Kynurenine pathway metabolism and the microbiota-gut-brain axis[J]. Neuropharmacology 112(Pt B):399\u2013412","journal-title":"Neuropharmacology"},{"issue":"1","key":"11357_CR62","first-page":"117","volume":"29","author":"M Maes","year":"2008","unstructured":"Maes M, Kubera M, Leunis JC (2008) The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett 29(1):117\u2013124","journal-title":"Neuro Endocrinol Lett"},{"issue":"38","key":"11357_CR63","doi-asserted-by":"publisher","first-page":"16050","DOI":"10.1073\/pnas.1102999108","volume":"108","author":"JA Bravo","year":"2011","unstructured":"Bravo JA, Forsythe P, Chew MV et al (2011) Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 108(38):16050\u201316055","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11357_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00049","volume":"12","author":"B Bonaz","year":"2018","unstructured":"Bonaz B, Bazin T, Pellissier S (2018) The vagus nerve at the interface of the microbiota-gut-brain axis. Front Neurosci 12:49","journal-title":"Front Neurosci"},{"key":"11357_CR65","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ynstr.2017.03.001","volume":"7","author":"JA Foster","year":"2017","unstructured":"Foster JA, Rinaman L, Cryan JF (2017) Stress & the gut-brain axis: regulation by the microbiome. Neurobiol Stress 7:124\u2013136","journal-title":"Neurobiol Stress"},{"issue":"7604","key":"11357_CR66","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature17998","volume":"533","author":"P Zanos","year":"2016","unstructured":"Zanos P, Moaddel R, Morris PJ et al (2016) NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533(7604):481\u2013486","journal-title":"Nature"},{"issue":"5994","key":"11357_CR67","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li N, Lee B, Liu RJ et al (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science (New York, N.Y.) 329(5994):959\u2013964","journal-title":"Science (New York, N.Y.)"},{"issue":"5","key":"11357_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2016.12.020","volume":"82","author":"C Yang","year":"2017","unstructured":"Yang C, Qu Y, Abe M et al (2017) Ketamine shows greater potency and longer lasting antidepressant effects than its metabolite (2R,6R)-hydroxynorketamine. Biol Psychiatry 82(5):e43-e44","journal-title":"Biol Psychiatry"},{"issue":"1","key":"11357_CR69","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/ijnp\/pyx108","volume":"21","author":"Y Shirayama","year":"2018","unstructured":"Shirayama Y, Hashimoto K (2018) Lack of antidepressant effects of (2R,6R)-hydroxynorketamine in a rat learned helplessness model: comparison with (R)-ketamine. Int J Neuropsychopharmacol 21(1):84\u201388","journal-title":"Int J Neuropsychopharmacol"},{"key":"11357_CR70","first-page":"1900","volume-title":"2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice[J]","author":"JI Yamaguchi","year":"2018","unstructured":"Yamaguchi JI, Toki H, Qu Y et al (2018) 2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice[J], vol 43. Official Publication of the American College of Neuropsychopharmacology, Neuropsychopharmacology, pp 1900\u20131907. 9"},{"issue":"11","key":"11357_CR71","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.1038\/s41380-021-01093-2","volume":"26","author":"J Bonaventura","year":"2021","unstructured":"Bonaventura J, Lam S, Carlton M et al (2021) Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability. Mol Psychiatry 26(11):6704\u20136722","journal-title":"Mol Psychiatry"},{"issue":"3","key":"11357_CR72","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.117.015198","volume":"70","author":"P Zanos","year":"2018","unstructured":"Zanos P, Moaddel R, Morris PJ et al (2018) Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Pharmacol Rev 70(3):621\u2013660","journal-title":"Pharmacol Rev"},{"issue":"3","key":"11357_CR73","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nm.4050","volume":"22","author":"RS Duman","year":"2016","unstructured":"Duman RS, Aghajanian GK, Sanacora G et al (2016) Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med 22(3):238\u2013249","journal-title":"Nat Med"},{"key":"11357_CR74","first-page":"1210","volume-title":"Ketamine treatment and global brain connectivity in major depression[J]","author":"CG Abdallah","year":"2017","unstructured":"Abdallah CG, Averill LA, Collins KA et al (2017) Ketamine treatment and global brain connectivity in major depression[J], vol 42. Official Publication of the American College of Neuropsychopharmacology, Neuropsychopharmacology, pp 1210\u20131219"},{"issue":"1","key":"11357_CR75","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.biopsych.2017.05.016","volume":"83","author":"C Yang","year":"2018","unstructured":"Yang C, Ren Q, Qu Y et al (2018) Mechanistic target of rapamycin-independent antidepressant effects of (R)-ketamine in a social defeat stress model. Biol Psychiatry 83(1):18\u201328","journal-title":"Biol Psychiatry"},{"issue":"7354","key":"11357_CR76","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature10130","volume":"475","author":"AE Autry","year":"2011","unstructured":"Autry AE, Adachi M, Nosyreva E et al (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475(7354):91\u201395","journal-title":"Nature"},{"issue":"5762","key":"11357_CR77","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1126\/science.1120972","volume":"311","author":"O Berton","year":"2006","unstructured":"Berton O, McClung CA, Dileone RJ et al (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311(5762):864\u2013868","journal-title":"Science"},{"issue":"1","key":"11357_CR78","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.tins.2011.11.004","volume":"35","author":"RS Duman","year":"2012","unstructured":"Duman RS, Voleti B (2012) Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents. Trends Neurosci 35(1):47\u201356","journal-title":"Trends Neurosci"},{"issue":"5","key":"11357_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.112","volume":"7","author":"JC Zhang","year":"2017","unstructured":"Zhang JC, Yao W, Dong C et al (2017) Blockade of interleukin-6 receptor in the periphery promotes rapid and sustained antidepressant actions: a possible role of gut-microbiota-brain axis. Transl Psychiatry 7(5):e1138","journal-title":"Transl Psychiatry"},{"key":"11357_CR80","first-page":"1609","volume-title":"NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL\/6J mice[J]","author":"AK Walker","year":"2013","unstructured":"Walker AK, Budac DP, Bisulco S et al (2013) NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL\/6J mice[J], vol 38. Official Publication of the American College of Neuropsychopharmacology, Neuropsychopharmacology, pp 1609\u20131616"},{"issue":"8","key":"11357_CR81","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s11011-021-00743-2","volume":"36","author":"DB Fraga","year":"2021","unstructured":"Fraga DB, Camargo A, Olescowicz G et al (2021) Ketamine, but not fluoxetine, rapidly rescues corticosterone-induced impairments on glucocorticoid receptor and dendritic branching in the hippocampus of mice. Metab Brain Dis 36(8):2223\u20132233","journal-title":"Metab Brain Dis"},{"issue":"8","key":"11357_CR82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071323","volume":"8","author":"FA Schroeder","year":"2013","unstructured":"Schroeder FA, Lewis MC, Fass DM et al (2013) A selective HDAC 1\/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related tests. PLoS One 8(8):e71323","journal-title":"PLoS One"},{"issue":"37","key":"11357_CR83","doi-asserted-by":"publisher","first-page":"11451","DOI":"10.1523\/JNEUROSCI.1758-09.2009","volume":"29","author":"HE Covington","year":"2009","unstructured":"Covington HE, Maze I, LaPlant QC et al (2009) Antidepressant actions of histone deacetylase inhibitors. J Neurosci 29(37):11451\u201311460","journal-title":"J Neurosci"},{"issue":"8","key":"11357_CR84","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.biopsych.2018.01.027","volume":"84","author":"JW Evans","year":"2018","unstructured":"Evans JW, Szczepanik J, Brutsch\u00e9 N et al (2018) Default mode connectivity in major depressive disorder measured up to 10 days after ketamine administration. Biol Psychiatry 84(8):582\u2013590","journal-title":"Biol Psychiatry"},{"issue":"12","key":"11357_CR85","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.biopsych.2013.02.008","volume":"73","author":"PJ Carlson","year":"2013","unstructured":"Carlson PJ, Diazgranados N, Nugent AC et al (2013) Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study. Biol Psychiatry 73(12):1213\u20131221","journal-title":"Biol Psychiatry"},{"issue":"2","key":"11357_CR86","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","volume":"75","author":"EJ Daly","year":"2018","unstructured":"Daly EJ, Singh JB, Fedgchin M et al (2018) Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial. JAMA Psychiatr 75(2):139\u2013148","journal-title":"JAMA Psychiatr"},{"key":"11357_CR87","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jad.2018.07.073","volume":"241","author":"M Sinyor","year":"2018","unstructured":"Sinyor M, Williams M, Belo S et al (2018) Ketamine augmentation for major depressive disorder and suicidal ideation: preliminary experience in an inpatient psychiatry setting. J Affect Disord 241:103\u2013109","journal-title":"J Affect Disord"},{"issue":"2","key":"11357_CR88","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1017\/S1461145713001119","volume":"17","author":"CN Haile","year":"2014","unstructured":"Haile CN, Murrough JW, Iosifescu DV et al (2014) Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression[J]. Int J Neuropsychopharmacol 17(2):331\u2013336","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"11357_CR89","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/ALN.0000000000000285","volume":"121","author":"RK Paul","year":"2014","unstructured":"Paul RK, Singh NS, Khadeer M (2014) (R,S)-ketamine metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine increase the mammalian target of rapamycin function. Anesthesiology 121(1):149\u2013159","journal-title":"Anesthesiology"},{"issue":"2","key":"11357_CR90","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jphs.2023.12.005","volume":"154","author":"R Yokoyama","year":"2024","unstructured":"Yokoyama R, Higuchi M, Tanabe W et al (2024) Long-lasting anti-despair and anti-anhedonia effects of (S)-norketamine in social isolation-reared mice. J Pharmacol Sci 154(2):72\u201376","journal-title":"J Pharmacol Sci"},{"issue":"1","key":"11357_CR91","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/14737175.2019.1554434","volume":"19","author":"K Zhang","year":"2019","unstructured":"Zhang K, Hashimoto K (2019) An update on ketamine and its two enantiomers as rapid-acting antidepressants. Expert Rev Neurother 19(1):83\u201392","journal-title":"Expert Rev Neurother"},{"issue":"7692","key":"11357_CR92","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature25509","volume":"554","author":"Y Yang","year":"2018","unstructured":"Yang Y, Cui Y, Sang K et al (2018) Ketamine blocks bursting in the lateral habenula to rapidly relieve depression. Nature 554(7692):317\u2013322","journal-title":"Nature"},{"issue":"6","key":"11357_CR93","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1021\/acschemneuro.2c00803","volume":"14","author":"A Majumdar","year":"2023","unstructured":"Majumdar A, Siva Venkatesh IP, Basu A (2023) Short-chain fatty acids in the microbiota-gut-brain axis: role in neurodegenerative disorders and viral infections. ACS chemical neuroscience 14(6):1045\u20131062","journal-title":"ACS chemical neuroscience"},{"issue":"7707","key":"11357_CR94","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41586-018-0119-x","volume":"557","author":"V Rothhammer","year":"2018","unstructured":"Rothhammer V, Borucki DM, Tjon EC et al (2018) Microglial control of astrocytes in response to microbial metabolites. Nature 557(7707):724\u2013728","journal-title":"Nature"},{"issue":"6","key":"11357_CR95","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/mp.2016.44","volume":"21","author":"P Zheng","year":"2016","unstructured":"Zheng P, Zeng B, Zhou C et al (2016) Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host\u2019s metabolism. Mol Psychiatry 21(6):786\u2013796","journal-title":"Mol Psychiatry"},{"issue":"6","key":"11357_CR96","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ijnp\/pyac020","volume":"25","author":"A Mastrodonato","year":"2022","unstructured":"Mastrodonato A, Pavlova I, Kee NC et al (2022) Prophylactic (R,S)-ketamine is effective against stress-induced behaviors in adolescent but not aged mice. Int J Neuropsychopharmacol 25(6):512\u2013523","journal-title":"Int J Neuropsychopharmacol"},{"issue":"7762","key":"11357_CR97","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","volume":"570","author":"M Zimmermann","year":"2019","unstructured":"Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R et al (2019) Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature 570(7762):462\u2013467","journal-title":"Nature"},{"issue":"11","key":"11357_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.191","volume":"6","author":"AP Allen","year":"2016","unstructured":"Allen AP, Hutch W, Borre YE et al (2016) Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers. Transl Psychiatry 6(11):e939","journal-title":"Transl Psychiatry"},{"issue":"2","key":"11357_CR99","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","volume":"161","author":"JM Yano","year":"2015","unstructured":"Yano JM, Yu K, Donaldson GP et al (2015) Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161(2):264\u2013276","journal-title":"Cell"},{"issue":"8","key":"11357_CR100","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile B, Van Oudenhove L, Vervliet B et al (2019) The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol 16(8):461\u2013478","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"11357_CR101","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1053\/j.gastro.2011.04.052","volume":"141","author":"P Bercik","year":"2011","unstructured":"Bercik P, Denou E, Collins J et al (2011) The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice[J]. Gastroenterology 141(2):599\u2013609","journal-title":"Gastroenterology"},{"issue":"24","key":"11357_CR102","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1111\/bph.14366","volume":"175","author":"J Walsh","year":"2018","unstructured":"Walsh J, Griffin BT, Clarke G et al (2018) Drug-gut microbiota interactions: implications for neuropharmacology. Br J Pharmacol 175(24):4415\u20134429","journal-title":"Br J Pharmacol"},{"key":"11357_CR103","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.neuroscience.2016.10.003","volume":"339","author":"AE Hoban","year":"2016","unstructured":"Hoban AE, Moloney RD, Golubeva AV et al (2016) Behavioural and neurochemical consequences of chronic gut microbiota depletion during adulthood in the rat. Neuroscience 339:463\u2013477","journal-title":"Neuroscience"},{"key":"11357_CR104","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/7854_2016_40","volume":"31","author":"E Haroon","year":"2017","unstructured":"Haroon E, Miller AH (2017) Inflammation effects on brain glutamate in depression: mechanistic considerations and treatment implications[J]. Curr Top Behav Neurosci 31:173\u2013198","journal-title":"Curr Top Behav Neurosci"},{"key":"11357_CR105","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbr.2014.07.027","volume":"277","author":"SM O\u2019Mahony","year":"2015","unstructured":"O\u2019Mahony SM, Clarke G, Borre YE et al (2015) Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res 277:32\u201348","journal-title":"Behav Brain Res"},{"issue":"3","key":"11357_CR106","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1177\/02698811221104058","volume":"37","author":"F Scott","year":"2023","unstructured":"Scott F, Hampsey E, Gnanapragasam S et al (2023) Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression. J Psychopharmacol 37(3):268\u2013278","journal-title":"J Psychopharmacol"},{"issue":"4","key":"11357_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2023.115954","volume":"106","author":"YE Beyhan","year":"2023","unstructured":"Beyhan YE, Y\u0131ld\u0131z MR (2023) Microbiota and parasite relationship. Diagn Microbiol Infect Dis 106(4):115954","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"12","key":"11357_CR108","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1001\/jamapsychiatry.2021.2573","volume":"78","author":"VL Nikolova","year":"2021","unstructured":"Nikolova VL, Smith MRB, Hall LJ et al (2021) Perturbations in gut microbiota composition in psychiatric disorders: a review and meta-analysis. JAMA Psychiatr 78(12):1343\u20131354","journal-title":"JAMA Psychiatr"},{"key":"11357_CR109","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jad.2017.11.063","volume":"228","author":"QX Ng","year":"2018","unstructured":"Ng QX, Peters C, Ho CYX et al (2018) A meta-analysis of the use of probiotics to alleviate depressive symptoms. J Affect Disord 228:13\u201319","journal-title":"J Affect Disord"},{"issue":"2","key":"11357_CR110","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1053\/j.gastro.2017.05.003","volume":"153","author":"MI Pinto-Sanchez","year":"2017","unstructured":"Pinto-Sanchez MI, Hall GB, Ghajar K et al (2017) Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology 153(2):448-459.e8","journal-title":"Gastroenterology"},{"issue":"4","key":"11357_CR111","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1161\/CIRCRESAHA.119.316448","volume":"127","author":"J Lee","year":"2020","unstructured":"Lee J, d\u2019Aigle J, Atadja L et al (2020) Gut microbiota-derived short-chain fatty acids promote poststroke recovery in aged mice. Circ Res 127(4):453\u2013465","journal-title":"Circ Res"},{"key":"11357_CR112","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.schres.2020.02.010","volume":"234","author":"JR Kelly","year":"2021","unstructured":"Kelly JR, Minuto C, Cryan JF et al (2021) The role of the gut microbiome in the development of schizophrenia. Schizophr Res 234:4\u201323","journal-title":"Schizophr Res"},{"issue":"1","key":"11357_CR113","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0791-y","volume":"15","author":"FN Jacka","year":"2017","unstructured":"Jacka FN, O\u2019Neil A, Opie R et al (2017) A randomised controlled trial of dietary improvement for adults with major depression (the \u201cSMILES\u201d trial). BMC Med 15(1):23","journal-title":"BMC Med"},{"issue":"1","key":"11357_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/s40101-016-0101-y","volume":"36","author":"E Deans","year":"2016","unstructured":"Deans E (2016) Microbiome and mental health in the modern environment. J Physiol Anthropol 36(1):1","journal-title":"J Physiol Anthropol"},{"issue":"7","key":"11357_CR115","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1080\/1028415X.2017.1411320","volume":"22","author":"N Parletta","year":"2019","unstructured":"Parletta N, Zarnowiecki D, Cho J et al (2019) A mediterranean-style dietary intervention supplemented with fish oil improves diet quality and mental health in people with depression: a randomized controlled trial (HELFIMED). Nutr Neurosci 22(7):474\u2013487","journal-title":"Nutr Neurosci"},{"issue":"9","key":"11357_CR116","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1001\/jamapsychiatry.2019.1189","volume":"76","author":"EJ Daly","year":"2019","unstructured":"Daly EJ, Trivedi MH, Janik A et al (2019) Efficacy of Esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial. JAMA Psychiatr 76(9):893\u2013903","journal-title":"JAMA Psychiatr"},{"issue":"4","key":"11357_CR117","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1124\/dmd.123.001605","volume":"52","author":"P Jimonet","year":"2024","unstructured":"Jimonet P, Druart C, Blanquet-Diot S et al (2024) Gut microbiome integration in drug discovery and development of small molecules. Drug Metab Dispos 52(4):274\u2013287","journal-title":"Drug Metab Dispos"},{"key":"11357_CR118","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.neuint.2016.06.011","volume":"99","author":"RM Stilling","year":"2016","unstructured":"Stilling RM, van de Wouw M, Clarke G et al (2016) The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis? Neurochem Int 99:110\u2013132","journal-title":"Neurochem Int"},{"issue":"7","key":"11357_CR119","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1136\/gutjnl-2019-319654","volume":"69","author":"TS Ghosh","year":"2020","unstructured":"Ghosh TS, Rampelli S, Jeffery IB et al (2020) Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries. Gut 69(7):1218\u20131228","journal-title":"Gut"},{"issue":"2","key":"11357_CR120","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3233\/JAD-171151","volume":"63","author":"GM Pasinetti","year":"2018","unstructured":"Pasinetti GM, Singh R, Westfall S et al (2018) The role of the gut microbiota in the metabolism of polyphenols as characterized by gnotobiotic mice. J Alzheimers Dis 63(2):409\u2013421","journal-title":"J Alzheimers Dis"},{"issue":"7758","key":"11357_CR121","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price J, Arze C, Ananthakrishnan AN et al (2019) Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569(7758):655\u2013662","journal-title":"Nature"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11357-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11357-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11357-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T14:02:21Z","timestamp":1765375341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11357-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":121,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11357"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11357-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"6 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This is a review. The Ethics Committee of Xiangyang Central Hospital has confirmed that no ethical approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All author confirms: that the work described has not been published before (except in the form of an abstract or as part of a published lecture, review, or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors; that its publication has been approved (tacitly or explicitly) by the responsible authorities at the institution where the work is carried out. The Authors agrees to publication in the Journal.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}}],"article-number":"181"}}